DR. DEEPAK SRIVASTAVA, M.D.
Medical Practice at Parnassus Ave, San Francisco, CA
License number
California C52178
Category
Medical Practice
Type
Pediatric Cardiology
Address
Address
505 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 476-1000
(415) 734-2716
(415) 355-0141 (Fax)
(415) 734-2716
(415) 355-0141 (Fax)
Personal information
See more information about DEEPAK SRIVASTAVA at radaris.comName
Address
Phone
1938 Conifer Ln, San Jose, CA 95132
35540 Purcell Pl, Fremont, CA 94536
619 Marina Blvd, San Francisco, CA 94123
601 Almarida Dr, Campbell, CA 95008
6151 Prospect Rd, San Jose, CA 95129
Organization information
See more information about DEEPAK SRIVASTAVA at bizstanding.comDeepak Srivastava MD
1650 Owens St, San Francisco, CA 94158
Industry:
Pediatric Cardiologist
Phone:
(415) 734-2716 (Phone)
Deepak Srivastava
Professional information
See more information about DEEPAK SRIVASTAVA at trustoria.com
Co-Founder At Bird2Ape Analytics
Co-Founder At Bird2Ape Analytics
Position:
Co-Founder at Bird2Ape Analytics, Technology Due Diligence and Development Advisor at Consulting Company
Location:
San Francisco Bay Area
Industry:
Renewables & Environment
Work:
Bird2Ape Analytics
- San Jose, CA since Jul 2012
-
Co-Founder
Consulting Company
- San Jose, CA since Jan 2011
-
Technology Due Diligence and Development Advisor
Nanoexa
Mar 2007 - Dec 2010
-
Chief Technology Officer
NASA Ames Research Center
Oct 1996 - Feb 2010
-
Manager, Computational Nanotechnology
Nanostellar
Mar 2005 - Jul 2006
-
Member Technical Advisory Board, Consultant
The Pennsylvania State University
1989 - 1996
-
Research Assistant Professor
Education:
University of Florida 1981 - 1988
Ph.D, Physics Delhi University 1978 - 1981
M.Sci/M.Phil, Physics University of Lucknow 1975 - 1977
B.Sc. (Hons), Physics
Ph.D, Physics Delhi University 1978 - 1981
M.Sci/M.Phil, Physics University of Lucknow 1975 - 1977
B.Sc. (Hons), Physics
Skills:
Nanotechnology, Materials Science, R&D, Nanomaterials, Characterization, Start-ups, Materials, Simulations, Solar Energy, Product Development, Cleantech, Renewable Energy, Thin Films, Physics, Semiconductors, Photovoltaics, Engineering, Solar Cells, Manufacturing
Interests:
Exploring new technology areas, bollywood films and music, american jazz, writing
Languages:
Hindi
Director At J. David Gladstone Institutes
Director At J. David Gladstone Institutes
Position:
Director at J. David Gladstone Institutes
Location:
San Francisco Bay Area
Industry:
Medical Practice
Work:
J. David Gladstone Institutes
since Jun 2005
-
Director
University of Texas Southwestern Medical Center
1996 - 2005
-
Professor
Harvard Medical School, Children's Hospital
1992 - 1994
-
Pediatric Cardiologist
Education:
The University of Texas Medical Branch at Galveston 1986 - 1990
Doctor of Medicine (M.D.), Medicine Rice University 1983 - 1986
Bachelor of Arts (B.A.), Biochemistry
Doctor of Medicine (M.D.), Medicine Rice University 1983 - 1986
Bachelor of Arts (B.A.), Biochemistry
Skills:
Molecular Biology, Cell Biology, Lifesciences, Cell Culture, Biochemistry, Biotechnology, Neuroscience, Genetics, Immunology, Cell, Genomics, PCR, Drug Discovery, Research, Cancer, Clinical Research, Science, Clinical Trials, Protein Chemistry, Pharmacology
Languages:
HIndi, Spanish
Deepak Srivastava, San Francisco CA
Deepak Srivastava, San Francisco CA
Specialties:
Pediatrics, Pediatric Cardiology, Cardiovascular Disease
Work:
Gladstone Institute
1650 Owens St, San Francisco, CA 94158 UCSF Medical Group Business Services
521 Parnassus Ave, San Francisco, CA 94143
1650 Owens St, San Francisco, CA 94158 UCSF Medical Group Business Services
521 Parnassus Ave, San Francisco, CA 94143
Education:
The University of Texas at Galveston (1990)
Dr. Deepak Srivastava, San Francisco CA - MD (Doctor of Medicine)
Dr. Deepak Srivastava, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Pediatric Cardiology
Address:
1650 Owens St SUITE 200, San Francisco 94158
(415) 355-0141 (Phone), (415) 355-0141 (Fax)
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
(415) 476-9000 (Phone)
505 Parnassus Ave, San Francisco 94143
(415) 476-1000 (Phone), (415) 476-4009 (Fax)
(415) 355-0141 (Phone), (415) 355-0141 (Fax)
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
(415) 476-9000 (Phone)
505 Parnassus Ave, San Francisco 94143
(415) 476-1000 (Phone), (415) 476-4009 (Fax)
Certifications:
Pediatric Cardiology, 2004, Pediatrics, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1650 Owens St SUITE 200, San Francisco 94158
505 Parnassus Ave, San Francisco 94143
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
Hazard ARH Regional Medical Center
100 Medical Center Dr, Hazard 41701
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
505 Parnassus Ave, San Francisco 94143
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
Hazard ARH Regional Medical Center
100 Medical Center Dr, Hazard 41701
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
Education:
Medical School
University of Texas At Galveston / Medical Branch
Graduated: 1990
Children's Hospital
University Ca Sf Med Center
University of Texas At Galveston / Medical Branch
Graduated: 1990
Children's Hospital
University Ca Sf Med Center
Owner, Nirvana Media Groups
Owner, Nirvana Media Groups
Position:
Owner at Nirvana Media Groups
Location:
San Francisco Bay Area
Industry:
Graphic Design
Work:
Nirvana Media Groups
-
Owner
Methods And Compositions For Modulating Angiogenesis
Methods And Compositions For Modulating Angiogenesis
US Patent:
2011017, Jul 14, 2011
Filed:
Jul 1, 2009
Appl. No.:
13/001604
Inventors:
Jason E. Fish - San Mateo CA, US
Deepak Srivastava - San Francisco CA, US
Deepak Srivastava - San Francisco CA, US
International Classification:
A61K 31/7088, C07H 21/04, C12N 15/63, A61P 35/00
US Classification:
514 44 A, 536 231, 514 44 R, 536 245, 4353201
Abstract:
The present invention provides compositions comprising antisense nucleic acids that reduce miR-126 levels in an endothelial cell. The present invention provides compositions comprising a target protector nucleic acid. The present invention provides methods of modulating angiogenesis in an individual, the methods generally involving administering to the individual an effective amount of an agent that increases or that decreases the level of miR-126 in endothelial cells of the individual.
Methods Of Modulating Smooth Muscle Cell Proliferation And Differentiation
Methods Of Modulating Smooth Muscle Cell Proliferation And Differentiation
US Patent:
2012009, Apr 19, 2012
Filed:
Mar 8, 2010
Appl. No.:
13/254984
Inventors:
Deepak Srivastava - San Francisco CA, US
Kimberly R. Cordes - San Francisco CA, US
Kimberly R. Cordes - San Francisco CA, US
International Classification:
A61K 31/7088, C12N 5/10, A61P 9/10, C07H 21/02, A61P 9/00, C12N 5/071, A61K 35/12
US Classification:
424 9321, 435377, 435325, 536 231, 514 44 R, 536 245, 514 44 A
Abstract:
The present disclosure provides methods of inducing smooth muscle cell differentiation. The present disclosure provides genetically modified cells comprising exogenous miR-143 and/or miR-145 nucleic acids; and artificial tissues comprising the genetically modified cells. The present disclosure provides methods and compositions for reducing pathological angiogenesis. The present disclosure provides methods of inducing therapeutic angiogenesis. The present disclosure provides methods, compositions, and devices for inhibiting vascular smooth muscle cell proliferation.
Methods Of Controlling Cell Proliferation
Methods Of Controlling Cell Proliferation
US Patent:
2012012, May 24, 2012
Filed:
Jul 16, 2010
Appl. No.:
13/383819
Inventors:
Chulan Kwon - Ellicott City MD, US
Deepak Srivastava - San Francisco CA, US
Deepak Srivastava - San Francisco CA, US
International Classification:
G01N 33/567, C12Q 1/37, G01N 33/53, C12N 5/0789, C12N 15/85
US Classification:
435 721, 435375, 435455, 435 792, 435 24
Abstract:
The present disclosure provides methods for increasing self-renewal/expansion of stem cells. The present disclosure provides methods of reducing uncontrolled cell proliferation. The present disclosure provides methods of identifying agents that modulate Notch1/-catenin binding, and methods of identifying agents that inhibit enzyme-mediated cleavage of Notch1 intracellular domain from Notch1 transmembrane domain.
Methods Of Generating Cardiomyocytes And Cardiac Progenitors And Compositions
Methods Of Generating Cardiomyocytes And Cardiac Progenitors And Compositions
US Patent:
2009018, Jul 23, 2009
Filed:
Jan 16, 2009
Appl. No.:
12/355519
Inventors:
DEEPAK SRIVASTAVA - SAN FRANCISCO CA, US
KATHRYN N. IVEY - SAN FRANCISCO CA, US
KATHRYN N. IVEY - SAN FRANCISCO CA, US
International Classification:
C12N 15/00, C12N 5/06
US Classification:
435455, 435325
Abstract:
The present disclosure provides methods of inducing cardiomyogenesis in a stem cell or progenitor cell, or in a population of stem cells or progenitor cells; and methods for expansion of (increasing the numbers of) cardiac progenitors. Cell compositions are also provided.